Osmosis Investment Management UK Ltd Takes $1.95 Million Position in AMETEK, Inc. $AME

Osmosis Investment Management UK Ltd bought a new position in AMETEK, Inc. (NYSE:AMEFree Report) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 8,072 shares of the technology company’s stock, valued at approximately $1,953,000.

Other institutional investors have also modified their holdings of the company. Sivia Capital Partners LLC acquired a new stake in AMETEK during the second quarter worth about $295,000. Baird Financial Group Inc. boosted its holdings in AMETEK by 16.1% in the 2nd quarter. Baird Financial Group Inc. now owns 16,784 shares of the technology company’s stock valued at $3,037,000 after purchasing an additional 2,323 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of AMETEK by 65.0% in the 2nd quarter. NewEdge Advisors LLC now owns 3,946 shares of the technology company’s stock valued at $714,000 after buying an additional 1,555 shares during the period. Sei Investments Co. increased its holdings in shares of AMETEK by 38.2% during the 2nd quarter. Sei Investments Co. now owns 223,227 shares of the technology company’s stock worth $40,392,000 after buying an additional 61,672 shares during the last quarter. Finally, Squarepoint Ops LLC increased its holdings in shares of AMETEK by 105.3% during the 2nd quarter. Squarepoint Ops LLC now owns 158,274 shares of the technology company’s stock worth $28,641,000 after buying an additional 81,178 shares during the last quarter. Hedge funds and other institutional investors own 87.43% of the company’s stock.

Insider Activity

In related news, insider David F. Hermance sold 6,608 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider directly owned 42,509 shares of the company’s stock, valued at $10,797,286. This represents a 13.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.54% of the stock is currently owned by company insiders.

AMETEK Price Performance

AME stock opened at $242.30 on Tuesday. The business’s 50-day moving average is $241.14 and its two-hundred day moving average is $232.11. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.21 and a quick ratio of 0.76. The firm has a market capitalization of $55.53 billion, a P/E ratio of 35.42, a P/E/G ratio of 3.06 and a beta of 0.98. AMETEK, Inc. has a 1 year low of $179.24 and a 1 year high of $261.16.

AMETEK (NYSE:AMEGet Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The technology company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $1.95 billion. During the same period last year, the business earned $1.78 EPS. The company’s revenue was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. Analysts anticipate that AMETEK, Inc. will post 8.32 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 15th. AMETEK’s payout ratio is presently 19.88%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AME. BNP Paribas Exane raised their target price on AMETEK from $270.00 to $280.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Mizuho set a $270.00 price target on AMETEK in a report on Friday, May 1st. Morgan Stanley raised their price objective on AMETEK from $235.00 to $245.00 and gave the stock an “equal weight” rating in a research report on Friday, July 10th. Wall Street Zen lowered shares of AMETEK from a “buy” rating to a “hold” rating in a report on Sunday, May 10th. Finally, Seaport Research Partners reaffirmed a “buy” rating and issued a $290.00 target price on shares of AMETEK in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $266.80.

View Our Latest Stock Analysis on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

See Also

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.